Boothbay Fund Management »

Xeris Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $96k 43k 2.21
2022-03-31 $83k 32k 2.56
2021-12-31 $89k 30k 2.92

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS
Fidelity Wise Origin Bitcoin SHS
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
MPM Oncology Impact Management
Geode Capital Management
Rosalind Advisors
Millennium Management
Nuveen Asset Management
CenterBook Partners
Morgan Stanley
Northern Trust
AQR Capital Management
Redmile Group
Ameriprise Financial
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Xeris Pharmaceuticals